Brief: Syros Pharmaceuticals Inc Q3 Loss Per Share $3.21

Syros Pharmaceuticals

14/11/2022 12:37

Nov 14 (Reuters) - Syros Pharmaceuticals Inc  SYRS.O :
    * SYROS PHARMACEUTICALS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES A CORPORATE UPDATE
    * Q3 LOSS PER SHARE $3.21
    * REVENUES WERE $3.9 MILLION FOR Q3 OF 2022 VERSUS $5.7
MILLION
FOR Q3 OF 2021
    * Q3 EARNINGS PER SHARE VIEW $-4.01, REVENUE VIEW $5.2
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw38drYna 
Further company coverage:  SYRS.O